Clinical trial
Liver Embolization Approaches for Tumor Management - Retrospective and Prospective Analysis of the Short-, Medium-, and Long-term Clinical Course of Patients Subjected to Embolization Treatment for Primary and Secondary Liver Neoplasms
NCT05714124 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liver Embolization Approaches for Tumor Management - Retrospective and Prospective Analysis of the Short-, Medium-, and Long-term Clinical Course of Patients Subjected to Embolization Treatment for Primary and Secondary Liver Neoplasms
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 21, 2021
- Completion date
- December 31, 2031
- Enrollment
- 580 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cholangiocarcinoma, hepatocellular carcinoma, metastatic cancer, metastatic colon cancer, metastatic gastric cancer, metastatic pancreatic cancer, primary liver cancer